160 related articles for article (PubMed ID: 25190364)
1. Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation.
Hemmerle T; Zgraggen S; Matasci M; Halin C; Detmar M; Neri D
J Dermatol Sci; 2014 Nov; 76(2):96-103. PubMed ID: 25190364
[TBL] [Abstract][Full Text] [Related]
2. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
[TBL] [Abstract][Full Text] [Related]
3. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
Hemmerle T; Neri D
Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
[TBL] [Abstract][Full Text] [Related]
4. Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.
Bootz F; Schmid AS; Neri D
Inflamm Bowel Dis; 2015 Aug; 21(8):1908-17. PubMed ID: 25993691
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
Hess C; Neri D
Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.
Schwager S; Renner S; Hemmerle T; Karaman S; Proulx ST; Fetz R; Golding-Ochsenbein AM; Probst P; Halin C; Neri D; Detmar M
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518687
[TBL] [Abstract][Full Text] [Related]
7. Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.
Hemmerle T; Doll F; Neri D
Proc Natl Acad Sci U S A; 2014 Aug; 111(33):12008-12. PubMed ID: 25092334
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of PD-L1 blockade with a potency-matched dual cytokine-antibody fusion protein leads to cancer eradication in BALB/c-derived tumors but not in other mouse strains.
De Luca R; Neri D
Cancer Immunol Immunother; 2018 Sep; 67(9):1381-1391. PubMed ID: 29971465
[TBL] [Abstract][Full Text] [Related]
9. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model.
Quattrone F; Sanchez AM; Pannese M; Hemmerle T; Viganò P; Candiani M; Petraglia F; Neri D; Panina-Bordignon P
Reprod Sci; 2015 Sep; 22(9):1143-52. PubMed ID: 25850899
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.
Wieckowski S; Hemmerle T; Prince SS; Schlienger BD; Hillinger S; Neri D; Zippelius A
Lung Cancer; 2015 Apr; 88(1):9-15. PubMed ID: 25682318
[TBL] [Abstract][Full Text] [Related]
11. IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.
Eijkelkamp N; Steen-Louws C; Hartgring SA; Willemen HL; Prado J; Lafeber FP; Heijnen CJ; Hack CE; van Roon JA; Kavelaars A
J Neurosci; 2016 Jul; 36(28):7353-63. PubMed ID: 27413147
[TBL] [Abstract][Full Text] [Related]
12. A human mAb specific to oncofetal fibronectin selectively targets chronic skin inflammation in vivo.
Trachsel E; Kaspar M; Bootz F; Detmar M; Neri D
J Invest Dermatol; 2007 Apr; 127(4):881-6. PubMed ID: 17185984
[TBL] [Abstract][Full Text] [Related]
13. The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate.
Pasche N; Frey K; Neri D
Angiogenesis; 2012 Mar; 15(1):165-9. PubMed ID: 22052195
[TBL] [Abstract][Full Text] [Related]
14. The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.
Hess C; Neri D
Cancer Immunol Immunother; 2015 May; 64(5):635-44. PubMed ID: 25722088
[TBL] [Abstract][Full Text] [Related]
15. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
Frey K; Zivanovic A; Schwager K; Neri D
Integr Biol (Camb); 2011 Apr; 3(4):468-78. PubMed ID: 21225052
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.
Franz M; Doll F; Grün K; Richter P; Köse N; Ziffels B; Schubert H; Figulla HR; Jung C; Gummert J; Renner A; Neri D; Berndt A
Int J Cardiol; 2015 Sep; 195():311-22. PubMed ID: 26056964
[TBL] [Abstract][Full Text] [Related]
17. Novel antibody-cytokine fusion proteins featuring granulocyte-colony stimulating factor, interleukin-3 and interleukin-4 as payloads.
Schmid AS; Tintor D; Neri D
J Biotechnol; 2018 Apr; 271():29-36. PubMed ID: 29438784
[TBL] [Abstract][Full Text] [Related]
18. The dose-dependent tumor targeting of antibody-IFNγ fusion proteins reveals an unexpected receptor-trapping mechanism in vivo.
Hemmerle T; Neri D
Cancer Immunol Res; 2014 Jun; 2(6):559-67. PubMed ID: 24795141
[TBL] [Abstract][Full Text] [Related]
19. Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.
Doll F; Schwager K; Hemmerle T; Neri D
Arthritis Res Ther; 2013 Sep; 15(5):R138. PubMed ID: 24289726
[TBL] [Abstract][Full Text] [Related]
20. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
